All In MedTech

FDA Clearance Tracker · P080006-S052

ATTAIN ABILITY LEAD

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 24, 2013 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P080006-S052
Device name
ATTAIN ABILITY LEAD
Applicant location
Minneapolis, MN
Received
Apr 10, 2013
Decided
Dec 24, 2013
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P080006

Device type

Device class
Class III

Every decision under product code OJX

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A RE-PACKAGING/RE-LABELING SITE LOCATED AT MEDTRONIC IN MEMPHIS, TENNESEE.

Source documents

Other decisions for Medtronic, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.